Changes in the innate immune response to SARS-CoV-2 with advancing age in humans

被引:4
作者
Agrawal S. [1 ,2 ]
Tran M.T. [1 ,2 ]
Jennings T.S.K. [3 ]
Soliman M.M.H. [1 ,2 ]
Heo S. [1 ,2 ]
Sasson B. [2 ]
Rahmatpanah F. [3 ]
Agrawal A. [1 ,2 ]
机构
[1] Division of Basic and Clinical Immunology, Department of Medicine, University of California Irvine, Irvine, 92697, CA
[2] Department of Medicine, University of California Irvine, Irvine, 92697, CA
[3] Department of Pathology, University of California Irvine, Irvine, 92697, CA
基金
美国国家卫生研究院;
关键词
Aging; CD8 T cells; DCs; IL-29; Monocytes; RNA-seq; SARS-CoV-2; innate immunity;
D O I
10.1186/s12979-024-00426-3
中图分类号
学科分类号
摘要
Background: Advancing age is a major risk factor for respiratory viral infections. The infections are often prolonged and difficult to resolve resulting hospitalizations and mortality. The recent COVID-19 pandemic has highlighted this as elderly subjects have emerged as vulnerable populations that display increased susceptibility and severity to SARS-CoV-2. There is an urgent need to identify the probable mechanisms underlying this to protect against future outbreaks of such nature. Innate immunity is the first line of defense against viruses and its decline impacts downstream immune responses. This is because dendritic cells (DCs) and macrophages are key cellular elements of the innate immune system that can sense and respond to viruses by producing inflammatory mediators and priming CD4 and CD8 T-cell responses. Results: We investigated the changes in innate immune responses to SARS-CoV-2 as a function of age. Our results using human PBMCs from aged, middle-aged, and young subjects indicate that the activation of DCs and monocytes in response to SARS-CoV-2 is compromised with age. The impairment is most apparent in pDCs where both aged and middle-aged display reduced responses. The secretion of IL-29 that confers protection against respiratory viruses is also decreased in both aged and middle-aged subjects. In contrast, inflammatory mediators associated with severe COVID-19 including CXCL-8, TREM-1 are increased with age. This is also apparent in the gene expression data where pathways related host defense display an age dependent decrease with a concomitant increase in inflammatory pathways. Not only are the inflammatory pathways and mediators increased after stimulation with SARS-CoV-2 but also at homeostasis. In keeping with reduced DC activation, the induction of cytotoxic CD8 T cells is also impaired in aged subjects. However, the CD8 T cells from aged subjects display increased baseline activation in accordance with the enhanced baseline inflammation. Conclusions: Our results demonstrate a decline in protective anti-viral immune responses and increase in damaging inflammatory responses with age indicating that dysregulated innate immune responses play a significant role in the increased susceptibility of aged subjects to COVID-19. Furthermore, the dysregulation in immune responses develops early on as middle-aged demonstrate several of these changes. Graphical abstract: (Figure presented.). © The Author(s) 2024.
引用
收藏
相关论文
共 80 条
  • [1] Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, pp. 507-513, (2020)
  • [2] Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet, 395, pp. 497-506, (2020)
  • [3] Pedersen S.F., Ho Y.C., SARS-CoV-2: A Storm is Raging, The Journal of Clinical Investigation, (2020)
  • [4] Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C., In Vitro antiviral activity and projection of optimized Dosing Design of Hydroxychloroquine for the treatment of severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clinical Infectious Diseases., (2020)
  • [5] Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., Et al., Clinical characteristics of Coronavirus Disease 2019 in China, N Engl J Med, (2020)
  • [6] Rothan H.A., Byrareddy S.N., The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J Autoimmun, (2020)
  • [7] Cocuzzo B., Wrench A., O'Malley C., Effects of COVID-19 on older adults: Physical, Mental, Emotional, Social, and financial problems seen and unseen, Cureus, 14, 9, (2022)
  • [8] Mansell V., Hall Dykgraaf S., Kidd M., Goodyear-Smith F., Long COVID and older people, Lancet Healthy Longev, 3, 12, pp. e849-e854, (2022)
  • [9] Taylor C.A., Patel K., Patton M.E., Reingold A., Kawasaki B., Meek J., Openo K., Ryan P.A., Falkowski A., Bye E., Et al., COVID-19-Associated hospitalizations among U.S. adults aged >/=65 years - COVID-NET, 13 States, January-August 2023, MMWR Morb Mortal Wkly Rep, 72, 40, pp. 1089-1094, (2023)
  • [10] Xu K., Wang Z., Qin M., Gao Y., Luo N., Xie W., Zou Y., Wang J., Ma X., A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults, Front Immunol, 14, (2023)